Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Kristoffer Hellstrand

Professor/ chief physician

Kristoffer Hellstrand
Professor/ chief physician
kristoffer.hellstrand@microbio.gu.se
+46 31 786 6672

Room number: Cancercentrum
Postal Address: Box 425, 40530 Göteborg
Visiting Address: Medicinaregatan 1F , 41390 Göteborg


Department of Infectious Diseases at Institute of Biomedicine (More Information)
Box 480
405 30 Göteborg
0313421000
Visiting Address: Guldhedsgatan 10 A-B , 413 46 Göteborg

Latest publications

IFNL4 Genotypes Predict Clearance of RNA Viruses in Rwandan Children With Upper Respiratory Tract Infections
Belson Rugwizangoga, Maria Andersson, Jean-Claude Kabayiza, Malin S. Nilsson, Brynja Armannsdóttir et al.
Frontiers in Cellular and Infection Microbiology, Journal article 2019
Journal article

Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
Hanna Grauers Wiktorin, Malin S. Nilsson, Roberta Kiffin, Frida Ewald Sander, Brianna Lenox et al.
Cancer Immunology Immunotherapy, Journal article 2019
Journal article

Showing 91 - 100 of 115

2004

2003

Immune response in blood and tumour tissue in patients with metastatic malignant melanoma treated with IL-2, IFN alpha and histamine dihydrochloride.
Andreas Schjellerup Jørkov, Frede Donskov, Torben Steiniche, Annika Ternesten-Bratel, Peter Naredi et al.
Anticancer research, Journal article 2003
Journal article

2002

Interleukin-2 and histamine dihydrochloride in metastatic melanoma.
Sanjiv S Agarwala, Kristoffer Hellstrand, Peter Naredi
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Journal article 2002
Journal article

Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II study.
F Donskov, H von der Maase, R Henriksson, U Stiemer, P Wersäll et al.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Journal article 2002
Journal article

Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma.
Sanjiv S Agarwala, John Glaspy, Steven J O'Day, Malcolm Mitchell, John Gutheil et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Journal article 2002
Journal article

2001

Showing 91 - 100 of 115

Page Manager: Chatrine Butler|Last update: 8/28/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?